INmune Bio Inc. (INMB)
8.11
0.52 (6.85%)
At close: Apr 02, 2025, 3:59 PM
INmune Bio Revenue
INmune Bio reported an annual revenue of $14K, reflecting a -90.97% growth. For the quarter ending December 31, 2024, INmune Bio generated $0 in revenue.
Revenue (ttm)
$14K
Revenue Growth
-90.97%
Price / Sales Ratio
6733.36
Revenue / Employee
$1.08K
Employees
13
Market Cap
185.96M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 14K | -90.97% |
| Dec 31, 2023 | 155K | -58.56% |
| Dec 31, 2022 | 374K | +106.63% |
| Dec 31, 2021 | 181K | +1558.12% |
| Dec 31, 2020 | 10.92K | n/a |